Have you been recently diagnosed with Waldenstrom Macroglobulinemia (WM)? Or would you like to understand more about WM, the treatment options and clinical trials?
Professor Trotman is a Sydney based clinical haematologist who has steered the Concord Research Unit towards leading recruitment in clinical trials in many lymphoma subtypes, including Waldenstrom’s Macrogobulinemia. Dr Trotman is the current chair of the Australasian Leukaemia and Lymphoma Group (ALLG) and has mentored clinical research fellow Dr Ibrahim Tohidi-Esfahani who was the co principal investigator on the WM Study Involving CART-WHEEL (WhiMSICAL). Dr Ibrahim Tohidi-Esfahani, together with Professor Judith Trotman, spearheaded an international team of patient and clinician investigators to expand the reach of WhiMSICAL, the world-first global patient-derived data registry for Waldenstrom’s Macroglobulinemia.
Join Professor Judith Trotman and Dr Ibrahim Tohidi-Esfahani as they provide you with information on WM
Please ensure you register below to receive updates about the event and the zoom link